Drugs / Chonline Alphoscerate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03059069 | Jun 2016 → Jun 2025 overdue | type 2 diabetes mellitus | Yonsei University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chonline Alphoscerate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03059069 ↗ |